Similar Papers

Paper Title
Journal
Date
Author
Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians.
Tyler Drake ... Adrienne Landsteiner
Annals of Internal Medicine | VOL. 177
Tyler Drake, et. al.Tyler Drake ... Adrienne Landsteiner
19 Apr 2024
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.
Clement Lo ... Yoichiro Hirakawa
The Cochrane database of systematic reviews | VOL. 9
Clement Lo, et. al.Clement Lo ... Yoichiro Hirakawa
24 Sep 2018
Key updates to the management of type 2 diabetes in adults: how to embrace and embed the new NICE guidance
Neel Basudev
Practical Diabetes | VOL. 39
Neel BasudevNeel Basudev
01 Sep 2022
Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes
Sean L Zheng ... Darrel Francis
JAMA | VOL. 319
Sean L Zheng, et. al.Sean L Zheng ... Darrel Francis
17 Apr 2018
View more papers

More From: Diabetes & Metabolism Journal

Paper Title
Journal
Date
Author
Association of Measures of Glucose Metabolism with Colorectal Cancer Risk in Older Chinese: A 13-Year Follow-up of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy and Meta-Analysis (Diabetes Metab J 2024;48:134-45).
Jin Hwa Kim
Diabetes & Metabolism Journal | VOL. 48
Jin Hwa KimJin Hwa Kim
31 Mar 2024
Association of Measures of Glucose Metabolism with Colorectal Cancer Risk in Older Chinese: A 13-Year Follow-up of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy and Meta-Analysis (Diabetes Metab J 2024;48:134-45).
Shu Yi Wang ... Lin Xu
Diabetes & Metabolism Journal | VOL. 48
Shu Yi Wang, et. al.Shu Yi Wang ... Lin Xu
31 Mar 2024
SGLT2 Inhibitors and GLP-1 Agonists: A Beacon of Hope for Stroke Prevention in Diabetes.
Jae-Han Jeon
Diabetes & Metabolism Journal | VOL. 48
Jae-Han JeonJae-Han Jeon
31 Mar 2024
Enhancing Patient Outcomes: Prioritizing SGLT2is and GLP-1RAs in Diabetes with CVD.
Gwanpyo Koh
Diabetes & Metabolism Journal | VOL. 48
Gwanpyo KohGwanpyo Koh
31 Mar 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.